14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
AXS vs RYAN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
AXS Captures Overall Composite Edge (38.6 SELL vs 40.7 SELL), While RYAN Leads 3–2 on Growth & Valuation Pillars
AXS Overall Winner
6-Pillar Tally: AXS 2 – 3 RYAN (1 Tie)
Matrix Metrics: AXS 5 – 4 RYAN
As of Nov 16, 2026, Axis Capital Holders Limited (AXS) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (38.6/100 SELL vs. 40.7/100 SELL) after splitting the core matrix 5–4 (led by Valuation Multiples, Growth & Scale), while RYAN wins 3–2 across the 6-pillar growth and valuation breakdown. AXS trades at $109.99 (8.2x Forward P/E, 18.2% operating margin) versus RYAN at $47.86 (19.7x Forward P/E, 19.8% operating margin).
Composite vs. Pillar Nuance: While RYAN currently prints a higher short-term Unified Composite Score (40.7/100 SELL vs. AXS 38.6/100 SELL), AXS captures the overall institutional head-to-head verdict (5–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (18.2% vs. 19.8% operating margin) and revenue trajectory (+6.9% vs. +4.8% YoY).
Defensive Composite Rating Caution: Although AXS compares more favorably head-to-head, both AXS (38.6/100 SELL) and RYAN (40.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXS vs RYAN. Trailing 12-month operating profitability (AXS 18.2% vs RYAN 19.8%) and valuation multiples (AXS 8.2x vs RYAN 19.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance - Specialty value chain with $7.8B market capitalization and 18.2% operating margin.
OpEx & R&D Reinvestment10.5% of Rev ($727M)
90D Engineering Disclosures0 Published
RYAN Moat ProfileScale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $11.9B market capitalization and 19.8% operating margin.
OpEx & R&D Reinvestment21.3% of Rev ($1.32B)
90D Engineering Disclosures0 Published
Investor FAQ AXS vs RYAN Key Questions & Quantitative Answers
As of Nov 16, 2026, Axis Capital Holders Limited (AXS) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (38.6/100 SELL vs. 40.7/100 SELL) after splitting the core matrix 5–4 (led by Valuation Multiples, Growth & Scale), while RYAN wins 3–2 across the 6-pillar growth and valuation breakdown. AXS trades at $109.99 (8.2x Forward P/E, 18.2% operating margin) versus RYAN at $47.86 (19.7x Forward P/E, 19.8% operating margin). Composite vs. Pillar Nuance: While RYAN currently prints a higher short-term Unified Composite Score (40.7/100 SELL vs. AXS 38.6/100 SELL), AXS captures the overall institutional head-to-head verdict (5–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (18.2% vs. 19.8% operating margin) and revenue trajectory (+6.9% vs. +4.8% YoY). Defensive Composite Rating Caution: Although AXS compares more favorably head-to-head, both AXS (38.6/100 SELL) and RYAN (40.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
AXS leads the Growth & Scale pillar: AXS posts +6.9% YoY revenue growth and -26.5% YoY earnings growth on $6.92B TTM revenue (28.7% gross margin, 18.2% operating margin), compared with RYAN at +4.8% YoY revenue growth and +43.1% YoY earnings growth on $6.20B TTM revenue (41.1% gross margin, 19.8% operating margin). On trailing 12-month operating scale, AXS generates $6.92B in USD-normalized revenue versus $6.20B for RYAN. In operating R&D and SG&A reinvestment, AXS deploys 10.5% of Rev ($727M) (0 90-day corporate R&D disclosures) versus 21.3% of Rev ($1.32B) (0 disclosures) for RYAN.
AXS screens cheaper on headline valuation multiples. AXS trades at 8.2x Forward P/E, 8.3x Trailing P/E, 1.18x PEG, and 1.1x EV/Revenue (19.1% EBITDA margin), whereas RYAN trades at 19.7x Forward P/E, 58.6x Trailing P/E, N/M PEG, and 1.9x EV/Revenue (28.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AXS (16.0% ROE) versus RYAN (25.1% ROE) capital efficiency.
In options market volatility and institutional positioning, AXS carries 18.7% implied volatility (35th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.14β · 20% Vol realized risk). By comparison, RYAN carries 29.7% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.32β · 39% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.